6DECEMBER - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comSince compliance is an integral part of ensuring patient safety, any violation of regulatory methods or non-compliance of standards could tarnish a company's reputation, which has a detrimental impact on revenue. Without modernizing compliance operations at pharma companies, it will likely become increasingly complex, if not impossible, for compliance to remain a strategic partner to the business--a position that took years to achieve. However, due to rising cyber-attacks and unethical practices, companies are becoming increasingly cautious about regulatory compliance. More and more pharmaceutical organizations are looking at how groundbreaking technologies like RPA and ML in pharma can automate and improve their regulatory compliance activities to deliver better productivity. With a significant reduction in the possibility of human errors, RPA can assist the pharmaceutical industry in meeting stringent standards and complex regulations. Effectual RPA integration can also reduce production and compliance costs, generating a higher ROI for pharma organizations. Companies must continuously adapt to changing regulatory requirements while effectively managing the associated costs and resources required to fulfil those requirements. Compliance management solutions that can take a holistic, proactive approach is the need of the hour. These vendors will allow the companies to identify quality issues before they impact production. Coupled with this, companies should also make regulatory compliance a part of their corporate strategy. It should include effective training, timely communication, regular internal monitoring and auditing, and support from the top management to compliance initiatives.That being said, companies should be able to transform compliance from being a "cost" to one that "delivers value and competitive advantage." On that note, we present to you a special edition on compliance. The companies featured in this edition offer innovative products coupled with outstanding support to energize your compliance initiatives.Let us know your thoughts.The Foundations of Pharmaceutical Compliance for BusinessesTECH OUTLOOKTECH OUTLOOKCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.DECEMBER - 02 - 2021, Vol 07 - Issue 18 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerJaxon JaseEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:David Parker
< Page 5 | Page 7 >